1. Nonsteroidal Anti‐Inflammatory Therapy: A Journey Toward Safety
    Catarina Pereira‐Leite et al, 2017, Medicinal Research Reviews CrossRef
  2. Molecularly Imprinted Materials for Controlled Release Systems
    Yagmur Yegin et al, 2016, Advanced Molecularly Imprinting Materials CrossRef
  3. Phospho-NSAIDs Have Enhanced Efficacy in Mice Lacking Plasma Carboxylesterase: Implications for their Clinical Pharmacology
    Chi C. Wong et al, 2015, Pharmaceutical Research CrossRef
  4. Use of rodents as models of human diseases
    ThierryF Vandamme, 2014, Journal of Pharmacy And Bioallied Sciences CrossRef
  5. Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect
    Liqun Huang et al, 2014, PLoS ONE CrossRef
  6. Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in mice
    Aryah Basu et al, 2024, Frontiers in Neuroscience CrossRef
  7. NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future
    Sandra Ramos-Inza et al, 2021, Journal of Medicinal Chemistry CrossRef
  8. The Antiangiogenic Effect and Ocular Pharmacology of Novel Modified Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Oxygen-Induced Retinopathy
    Wei Huang et al, 2023, Journal of Ocular Pharmacology and Therapeutics CrossRef
  9. The Chemopreventive Efficacies of Nonsteroidal Anti-inflammatory Drugs: The Relationship of Short-term Biomarkers to Long-term Skin Tumor Outcome
    Carol D. Mikulec et al, 2013, Cancer Prevention Research CrossRef
  10. Topically Applied Phospho-Sulindac Hydrogel is Efficacious and Safe in the Treatment of Experimental Arthritis in Rats
    George Mattheolabakis et al, 2013, Pharmaceutical Research CrossRef
  11. Anti-Proliferative Effects of Piroxicam and Nimesulide on A431 Human Squamous Carcinoma Cell Line
    Faezeh Khodaie et al, 2017, International Journal of Cancer Management CrossRef
  12. Nanoemulsions and nanoparticles for non-melanoma skin cancer: effects of lipid materials
    P. Severino et al, 2013, Clinical and Translational Oncology CrossRef
  13. The ocular pharmacokinetics and biodistribution of phospho-sulindac (OXT-328) formulated in nanoparticles: Enhanced and targeted tissue drug delivery
    Ziyi Wen et al, 2019, International Journal of Pharmaceutics CrossRef
  14. Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics
    KA-WING CHENG et al, 2013, International Journal of Oncology CrossRef